Equity Analysis

Quarterly Results

    Alivus Life Sciences Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    543322
    INE03Q201024
    207.1673323
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ALIVUS
    31.92
    13517.83
    EPS(TTM)
    Face Value()
    Div & Yield %:
    34.56
    2
    2.04
     
Quarters
(RupeeIcon Cr)
ParticularsSep 2024Jun 2024Mar 2024
Gross Sales506.88588.62536.60
Other Operating Income0.000.000.00
Other Income 8.535.493.13
Total Income515.41594.11539.73
Total Expenditure 372.52429.13395.15
PBIDT142.89164.98144.58
Interest 0.340.350.36
PBDT142.55164.63144.21
Depreciation15.0914.3914.53
Tax30.2437.5231.05
Fringe Benefit Tax0.000.000.00
Deferred Tax1.901.240.69
Reported Profit After Tax95.32111.4897.94
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item95.32111.4897.94
EPS (Unit Curr.)7.789.107.99
EPS (Adj) (Unit Curr.)7.789.107.99
Calculated EPS (Unit Curr.)7.789.107.99
Calculated EPS (Adj) (Unit Curr.)7.789.107.99
Calculated EPS (Ann.) (Unit Curr.)31.1236.4031.97
Calculated EPS (Adj) (Ann.) (Unit Curr.)31.1236.4031.97
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity24.5124.5124.51
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)28.1928.0326.94
PBDTM(%)28.1227.9726.87
PATM(%)18.8118.9418.25
Dividend Per Share(Rs)0.000.000.00
Diluted EPS7.759.087.97